Therefore, functional inhibition of key inflammatory cytokines, such as IL-6, IL-1β, and/or IL-17, which are critical for the development of pathogenic T cell responses and viral persistence, may prevent the pathogenesis of TMEV-induced demyelinating disease. This evidence concerns the gene IL17A and demyelinating disease.